Turn your website into a research center by adding headline feeds and a magazine article search engine covering topics relevant to your site.

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

See Also

Health Health / Illness, Injury & Treatments Health / Medical Practice Science & Technology / Biology & Life Sciences

Current Medical Articles

BusinessWeek May 15, 2008 Arlene Weintraub	What the Doctors Aren't Disclosing A new study shows how authors of medical journal articles flout rules on revealing conflicts of interest.
Information Today May 15, 2008	ProQuest Hospital Collection Makes Its Debut The new ProQuest Hospital Collection has five health and medicine databases and includes full-text articles from 2,100 medical journals.
The Motley Fool May 15, 2008 Brian Orelli	So-So Syneron A little growth is an acceptable outcome in the struggling medical laser industry.
The Motley Fool May 15, 2008 Brian Lawler	You're Kidding Me, Cardiome! Canadian pharmaceutical company Cardiome is still awaiting an FDA decision on its lead drug.
The Motley Fool May 15, 2008 Brian Lawler	What's Cooking at Flamel? The drugmaker makes finding partners to help pay for its hepatitis C and diabetes compounds a top priority.
The Motley Fool May 15, 2008 Brian Orelli	Wanted: FDA Approval -- Pronto Teva and Amphastar have the courts on their side, but the FDA still stands in the way of a generic-drug launch.
Chemistry World May 14, 2008 Simon Hadlington	Bird Flu's Drug Resistance Mapped UK scientists have shown exactly why a mutant version of the deadly bird flu virus H5N1 becomes resistant to the drug oseltamivir - marketed as Tamiflu.
The Motley Fool May 14, 2008 Brian Lawler	Teaching Old Drugs New Tricks Pfizer's top drugs post mixed results in recent off-label studies.
The Motley Fool May 14, 2008 Brian Orelli	Abbott Knocks Down Boston Scientific Abbott Labs proves its drug-eluting device works better than its competitors as it presented more data from its ongoing Spirit III trial.
The Motley Fool May 13, 2008 Brian Lawler	Sanofi Can't Shake the Generics A new threat to the pharmaceutical's top drug may have arrived.
The Motley Fool May 13, 2008 Rich Duprey	Healthways Doesn't Need a Ventilator Several temporary setbacks have been reflected in Healthways' stock, which has tumbled more than 50% this year.
The Motley Fool May 13, 2008 Brian Orelli	Is Merck Keeping Its Enemies Close? The drugmaker strikes a deal with an Indian generic company.
The Motley Fool May 13, 2008 Brian Orelli	Omrix's Wild Ride High-growth stocks like Omrix Pharmaceutical can be hard to value. Not only are growing revenues hard to predict, but expenses can fluctuate wildly as the company grows.
The Motley Fool May 12, 2008 Brian Orelli	Merging Mylan Meanders Through 2008 In the larger-is-better world of generic-drug makers, it's kind of surprising that investors haven't yet gotten behind the Mylan/Merck KGaA deal.
The Motley Fool May 12, 2008 Brian Orelli	Lowering the Barr Barr Pharmaceuticals disappoints by lowering expectations.
The Motley Fool May 12, 2008 Brian Lawler	Hep C Drugs Slug It Out Does Vertex's telaprevir really trump Schering's boceprevir?
Popular Mechanics May 8, 2008 Chris Ladd	Autonomous 3D Robot Doc Gets X-Ray Powers With DIY A.I. Looks like the robotic uprising could be headed for the OR after all: Bots can now see through your flesh in three dimensions and direct a mechanical arm to perform a biopsy.
BusinessWeek May 8, 2008 Arlene Weintraub	Big Drug R&D on Campus With pipelines drying up, drugmakers are enlisting universities to help create new treatments.
BusinessWeek May 8, 2008 Arlene Weintraub	The Doctor vs. Device Makers Dr. Charles Rosen is on a mission to end the conflicts of interest between manufacturers and physicians.
Chemistry World May 8, 2008 Hepeng Jia	China to fast track pioneering drugs China is to speed up the approval of groundbreaking new drugs in an effort to encourage innovation in its pharmaceutical sector, a State Food and Drug Administration (SFDA) official has revealed.
The Motley Fool May 7, 2008 Brian Orelli	Black Onyx, but Not for Long Onyx posts a stellar quarter, but earnings for the pharmaceuticals company are headed in the other direction for the rest of the year.
The Motley Fool May 7, 2008 Brian Orelli	Teva's on a Tear The generic-drug maker can't be stopped.
The Motley Fool May 7, 2008 Brian Lawler	Cephalon's Long Shot Falls Short An FDA advisory panel brings bad news for the company.
The Motley Fool May 6, 2008 Brian Orelli	A Sign of the Pharma Times Merck is the latest big pharma cutting jobs to improve its bottom line.
The Motley Fool May 6, 2008 Brian Lawler	MannKind Moves Ahead The pharmaceutical awaits pivotal data on its lead drug Technosphere.
The Motley Fool May 6, 2008 Steven Renaldi	McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry.
Information Today May 5, 2008	Premerus Introduces Medical Misdiagnosis Portal Premerus provides a platform for consumers to read and post their own experiences to share insights about the impact of diagnostic errors.
The Motley Fool May 5, 2008 Brian Orelli	A Short Wait for Discovery Labs? The company gets a third letter about Surfaxin, but should be able to satisfy the FDA soon.
The Motley Fool May 5, 2008 Brian Lawler	Good News for Abuse-Resistant Drugs Drug developers working on harder-to-abuse pain remedies, including Pain Therapeutics, King Pharmaceuticals, and Alpharma, got a guarded thumbs-up from the FDA last week.
The Motley Fool May 2, 2008 Brian Orelli	Sepracor Diversifies to Sleep Better With its two top drugs in decline, diversification was the only answer for Sepracor.
The Motley Fool May 2, 2008 Steven Renaldi	Cardinal Health Gets Its Nest in Order Share price rises as investors hope the company is beginning to put some of its troubles behind it.
BusinessWeek May 1, 2008 Bruce Einhorn	Made in China: MRI Machines Medical device makers are stepping up manufacturing on the mainland, raising safety concerns.
The Motley Fool May 1, 2008 Brian Lawler	Soliris Brightens Alexion's Quarter Alexion Pharmaceuticals' lone drug posts gargantuan growth.
The Motley Fool May 1, 2008 Brian Lawler	Glaxo's Global Growth Gambit The pharmaceutical's new CEO has changes in mind.
Chemistry World May 2008 Derek Lowe	In the pipeline The controversy over cholesterol drug Vytorin has been going on for months. Surveying the wreckage, my first thought is: what a terrible shame the whole affair is.
The Motley Fool April 30, 2008 Brian Lawler	Pfizer Protects Profitable Patent The courts uphold a key patent on Pfizer's top drug.
The Motley Fool April 30, 2008 Brian Lawler	The Start of a New Endo The drugmaker marks its first quarter under new management.
The Motley Fool April 30, 2008 Brian Lawler	Idenix Aims for a Comeback This drugmaker may be down, but it's not yet out.
The Motley Fool April 30, 2008 Brian Lawler	Alexza Advances 2 More Drugs The pharmaceutical company's compounds keep zipping through clinical trials.
The Motley Fool April 30, 2008 Brian Lawler	A Dominating Danish Drugmaker Novo Nordisk turns in solid first-quarter financial numbers.
The Motley Fool April 30, 2008 Brian Lawler	A Tale of 2 DNA Drugs More trouble for Genentech's No. 2 product, the systemic lupus treatment Rituxan.
The Motley Fool April 30, 2008 Brian Orelli	Medco's Far-From-Generic Quarter Pharmacy benefit manager Medco Health Solutions benefits from new generic drugs.
The Motley Fool April 30, 2008 Brian Lawler	BioMarin's Bodacious Earnings BioMarin raises revenue guidance for all of its marketed drugs, thanks to strong sales so far in 2008.
The Motley Fool April 29, 2008 Brian Lawler	Sciele's Blue-Moon Buyback The specialty pharmaceutical surprisingly renews its share repurchase plan.
The Motley Fool April 29, 2008 Brian Orelli	Will These Drugs Get FDA Approval? Discovery Laboratories and Adolor are waiting FDA decisions on their drugs next month.
The Motley Fool April 29, 2008 Brian Lawler	Medarex Takes Another Hit Its lead cancer-fighting drug suffers a regulatory delay.
The Motley Fool April 29, 2008 Brian Lawler	So Pharmasset, So Good Early data hints at a promising hepatitis C treatment.
The Motley Fool April 29, 2008 Brian Orelli	Merck's Recovery Flushed Down Merck's best hope at recovery fails approval by the FDA.
Chemistry World April 25, 2008 James Mitchell Crow	Drug Costs Cut on World Malaria Day Swiss pharmaceuticals firm Novartis has announced it will reduce by one fifth the price it charges governments and NGOs for artemisinin-based antimalarial Coartem.
Chemistry World April 24, 2008 James Mitchell Crow	FDA takes tough line on biologic drug The US Food and Drug Administration has rejected an application from biotechnology firm Genzyme to make its already-approved, protein-based drug Myozyme in larger batches.
Fast Company May 2008 Greg Lindsay	Medical Leave Your next heart surgery could well be in Bangkok -- but don't worry, it'll be "in network." How your health care is taking wing ...
Chemistry World April 17, 2008 Nuala Mora	World's first therapeutic cancer vaccine approved In move that will be a fillip to cancer vaccine developers, US biotech Antigenics has won Russian approval to market Oncophage to treat kidney cancer.
Chemistry World April 9, 2008 Richard Van Noorden	The shortest recipe for Tamiflu US chemists have published the shortest synthesis to date of oseltamivir (Tamiflu), the anti-influenza drug which is also used to treat bird flu.
Chemistry World April 14, 2008 Ananyo Bhattacharya	Psychiatric Drug Ads 'Frequently Misleading' Advertisements for psychiatric drugs - including many top-selling antidepressants - often make claims that are either misleading or impossible to verify, according to a new US study.
Reason April 2008 Ronald Bailey	Medical Speech As a 1997 law expires, the FDA is mulling a plan allowing companies to disseminate unabridged reprints of "truthful and non-misleading" medical journal articles describing "off-label" uses of approved medications to physicians.
Chemistry World April 9, 2008 Mark Peplow	vCJD filter for blood could be in use 'by summer' ProMetic's prion filter, attached to a blood pack, is being marketed by French medical equipment company MacoPharma to clean blood of the proteins responsible for variant Creutzfeldt-Jakob disease (vCJD).
Managed Care March 2008 Martin Sipkoff	The Epilepsy Battle in the War Between Brands and Generics Brand-name manufacturers and many neurologists see danger in generic substitution, but the FDA insists that the practice is safe
Managed Care March 2008 Lola Butcher	Health Plans Come Together for Better Outcomes Research Companies that participate in large research cooperatives such as the HMO Research Network are helping the whole medical system
Managed Care March 2008 Kathryn J. Alexander	Health Plans Embrace Retail Clinics Convenient care clinics, as they like to be called, are spreading quickly because members and plans like them
Managed Care March 2008 Neil Versel	Health 2.0: Will Its Promise Be Realized? Advocates say new health care websites will transform health care; detractors warn against overestimating the potential
Managed Care March 2008 John Carroll	Should Plans Pay Physicians To Switch Patients to Generics? The AMA calls it a kickback, but the industry sees it as just good practice to give doctors an incentive to get patients on equivalent generics
Managed Care March 2008	Proposed 2009 HEDIS Measures Address Immunization, Obesity Rates The National Committee for Quality Assurance wants to expand what the committee's Healthcare Effectiveness Data and Information Set (HEDIS) measures look at in 2009.
Managed Care March 2008	Drug Caps Lower Spending, but .... These policies tend to make consumers shoulder some of the cost of prescriptions and the cost could be a barrier to medication adherence.
Managed Care March 2008	New Drug Abuse Codes Adopted The American Medical Association says that new CPT codes it developed should make it easier for health plans to determine whether doctors have screened for drug abuse.
Managed Care March 2008 Tony Berberabe	Headlines On Deadline ... The Cleveland Clinic has joined with the Internet giant Google to test a secure exchange of patient medical record data involving prescriptions, conditions, and allergies.
Managed Care March 2008 Martin Sipkoff	PBMs' Rebate Income Threatened By Lawsuits and Move to Generics A recent court settlement may affect the way the PBM industry makes profits, but could it also lead to higher drug costs?
Managed Care March 2008	CMS Hybrid Payment System Shows Promise Combining Medicare fee-for-service payments with new incentive programs could help physician groups save money for Medicare and reach quality-of-care targets.
Managed Care March 2008	PDP Drug Restrictions Block Comparison Shopping A review of 169 commonly used drugs covered by Medicare Prescription Drug Plans (PDPs) reveals that only 4 of the 10 largest plans by enrollment have all of those 169 drugs on formulary.
Managed Care March 2008	Specialty Drug Spending to Double by 2010 Additional indications for existing products, rather than new products, account for the bulk of increased specialty drug use.
Chemistry World April 3, 2008 Rebecca Trager	GSK Challenge to US Patent Rules Successful A US district court has said that the US patent office cannot introduce new rules that drug firms argued were a threat to innovation.
There are 5088 old articles available for this category.